Our Expertise
Cielo brings unparalleled expertise to the field of oncology imaging, with a dedicated team of specialists boasting extensive experience across a spectrum of cancer types and therapeutic modalities. Our team comprises renowned key opinion leaders in radiology and clinical oncology, alongside skilled medical imaging experts, oncology study coordinators, biomedical engineers, statisticians, and allied support personnel.
Comprehensive Services
We collaborate with a global network of sites to deliver a comprehensive suite of imaging services, encompassing image quality assessments, reconciliation, post-processing, and beyond. Leveraging advanced technologies such as CT, MRI, PET-CT, Nuclear Medicine, and Ultrasound, we ensure precise tumour phenotyping, staging, and early outcome prediction to meet the rigorous demands of oncology trials.
Unrivalled Dedication
Cielo is a trusted partner in advancing cancer research. Our specialists have mastered a multitude of evaluation criteria, including RECIST, mRECIST, PIRADS, LIRADS,BIRAD, TIRADs, VIRADS, CADRAD, Choi, RANO, Cheson, Lugano Classification, Halleck, iRECIST, RECIL, iRANO/bmRANO/pedRANO, PCWG, and PCWG3, providing unparalleled insights for informed decision-making throughout the drug development & research process.
Indications We Support
Cielo's expertise spans a wide range of cancer indications, including but not limited to:
- Breast [BIRADs]
- Colorectal
- Gastric
- Glioblastoma
- Glioma
- Head and Neck
- Lung
- Lymphoma
- Melanoma
- Ovarian
- Prostate
- Renal Cell
Innovative Solutions for Tomorrow's Challenges
As the landscape of oncology continues to evolve with the emergence of targeted therapies and personalized immunotherapy, Cielo remains committed to delivering cutting-edge solutions that drive efficiency, accuracy, and ultimately, better outcomes for patients worldwide. Trust Cielo to be your partner of choice in navigating the complexities of oncology clinical trials, enabling you to bring transformative therapies or products to market with confidence.